HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edward R. Munnell Emery Dilling Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Munnell, E. R. Articles by Mohr, J. A. Search for Related Content PubMed PubMed Citation Articles by Munnell, E. R. Articles by Mohr, J. A.

Ann Thorac Surg 1978;25:289-297
© 1978 The Society of Thoracic Surgeons

---

Articles

Reappraisal of Solitary Bronchiolar (Alveolar Cell) Carcinoma of the Lung

Departments of Surgery, Pathology, and Medicine, University of Oklahoma College of Medicine and the Oklahoma City Clinic, Oklahoma City, OK.

^* Address reprint requests to Dr. Munnell, 301 NW 12th St, Oklahoma City, OK 73103

Twelve patients with solitary bronchiolar carcinoma had lobectomy and were followed for up to 16 years. The concept of a multicentric origin of bronchiolar carcinoma, maintained for more than eight decades, should be discarded. The neoplasm arises indolently and usually in an area of pulmonary fibrosis. After lobectomy patients can now expect to follow one of four courses: (1) to be alive and well without recurrence; (2) after several years to have pulmonary recurrence or a new carcinoma; (3) with minute spread at the time of lobectomy to have metastasis develop in a short period; or (4) to die of unrelated conditions. The overall 5-year survival with this tumor is about 75%. Late recurrence or the development of another primary tumor, however, prompts the need for prolonged follow-up. Immunologically, patients have circulating antibodies when well and demonstrable circulating antigens with recurrence. The survival rate of selected patients with solitary bronchiolar carcinoma (eliminating those patients with microscopic spread from the primary neoplasm at the time of resection and those dying of other causes) was 100% after 5 years and 75% after 10 years.

This article has been cited by other articles:

				N. Kikuchi, H. Satoh, K. Sekizawa, and S. Ishikawa Late recurrence after resection of stage I lung adenocarcinoma Ann. Thorac. Surg., March 1, 2003; 75(3): 1069 - 1070. [Full Text] [PDF]

				O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47. [Abstract] [Full Text] [PDF]

				C.-P. Hsu, C.-Y. Chen, and N.-Y. Hsu BRONCHIOLOALVEOLAR CARCINOMA J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 374 - 381. [Abstract] [Full Text]